Esentra Injection Denosumab 120mg

About Esentra Injection Denosumab 120mg

Esentra Injection, which contains denosumab (120 mg), is a medication commonly used to treat certain bone-related conditions. Denosumab is a monoclonal antibody that works by inhibiting a protein called RANKL, which plays a role in the formation, function, and survival of osteoclasts (cells that break down bone). By inhibiting RANKL, denosumab helps reduce bone resorption, thereby increasing bone density and reducing the risk of fractures.

Esentra (denosumab) is typically used to:

1. Treat osteoporosis in postmenopausal women and men at high risk of fractures.
2. Prevent bone fractures in patients with bone metastases from cancer.
3. Treat giant cell tumor of bone.
4. Treat conditions related to bone loss due to certain cancers or treatments.

This injection is usually administered once every six months for osteoporosis treatment, but the specific dosage and frequency can vary based on the condition being treated and the healthcare provider's recommendations.

• If you have any specific questions about this medication or how it applies to your situation, its always best to consult your healthcare provider.

 

Advanced Bone Health Solution

Esentra Injection Denosumab 120mg is formulated to provide optimal support in the management of bone health disorders. Its effectiveness in hospital care arises from its targeted action against bone resorption, ensuring better patient outcomes. Medical professionals trust this product for its consistent results and reliability.


Trusted Source and Quality Assurance

Produced by leading manufacturers and exporters in India, Esentra Injection meets stringent quality standards. Hospitals and healthcare providers can rely on its efficacy and safety, backed by a 12-month shelf life and meticulous production processes to maintain potency and purity until administered.